` PGHL (Procter & Gamble Health Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

PGHL
vs
B
BSE Sensex 30

Over the past 12 months, PGHL has outperformed BSE Sensex 30, delivering a return of +12% compared to the BSE Sensex 30's +4% growth.

Stocks Performance
PGHL vs BSE Sensex 30

Loading
PGHL
BSE Sensex 30
Add Stock
www.alphaspread.com

Performance Gap
PGHL vs BSE Sensex 30

Loading
PGHL
BSE Sensex 30
Difference
www.alphaspread.com

Performance By Year
PGHL vs BSE Sensex 30

Loading
PGHL
BSE Sensex 30
Add Stock

Competitors Performance
Procter & Gamble Health Ltd vs Peers

BSE Sensex 30
PGHL
LLY
JNJ
NOVO B
ROG
Add Stock

Procter & Gamble Health Ltd
Glance View

Market Cap
95.6B INR
Industry
Pharmaceuticals

In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.

PGHL Intrinsic Value
3 306.82 INR
Overvaluation 43%
Intrinsic Value
Price
Back to Top